UBS’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$1.12M Buy
45,048
+4,477
+11% +$111K ﹤0.01% 2594
2014
Q2
$916K Sell
40,571
-44,106
-52% -$996K ﹤0.01% 2755
2014
Q1
$2.06M Sell
84,677
-32,248
-28% -$785K ﹤0.01% 2105
2013
Q4
$2.92M Sell
116,925
-96,759
-45% -$2.42M ﹤0.01% 1785
2013
Q3
$5.87M Buy
213,684
+107,554
+101% +$2.95M 0.01% 1193
2013
Q2
$1.93M Buy
+106,130
New +$1.93M ﹤0.01% 1891